Search research articles
Contact Us
Filters
Showing results (151-160 of 362) with videos related to
Page
of 37
Sort By:
Translational Oncology
|
May 20, 2014
Low-Dose Vascular Photodynamic Therapy Decreases Tumor Interstitial Fluid Pressure, which Promotes Liposomal Doxorubicin Distribution in a Murine Sarcoma Metastasis Model
Jean Yannis Perentes, Yabo Wang, Xingyu Wang, et al.
Translational Lung Cancer Research
|
February 11, 2021
Impact of an enhanced recovery after surgery pathway on thoracoscopic lobectomy outcomes in non-small cell lung cancer patients: a propensity score-matched study
Céline Forster, Valérie Doucet, Jean Yannis Perentes, et al.
Cancer Treatment Reviews
|
May 11, 2024
NTRK gene fusion testing and management in lung cancer
Matteo Repetto, Marina Chiara Garassino, Herbert H Loong, et al.
Journal for Immunotherapy of Cancer
|
October 25, 2022
Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse events
Alexander Coukos, Julien Vionnet, Michel Obeid, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 7, 2020
Quantifying potential confounders of panel-based tumor mutational burden (TMB) measurement
Jan Budczies, Daniel Kazdal, Michael Allgäuer, et al.
Nature Communications
|
May 1, 2024
Primary prophylaxis with mTOR inhibitor enhances T cell effector function and prevents heart transplant rejection during talimogene laherparepvec therapy of squamous cell carcinoma
Victor Joo, Karim Abdelhamid, Alessandra Noto, et al.
Journal of Thoracic Disease
|
March 12, 2026
The value of positron emission tomography scan in predicting pathologic response of non-small cell lung cancer managed by neoadjuvant chemo-immunotherapy
Louis-Emmanuel Chriqui, Maged Zaher, Etienne Abdelnour-Berchtold, et al.
The Lancet. Respiratory Medicine
|
April 13, 2020
Challenges in lung cancer therapy during the COVID-19 pandemic
Luana Calabrò, Solange Peters, Jean-Charles Soria, et al.
Future Oncology (London, England)
|
September 4, 2024
The KEYVIBE program: vibostolimab and pembrolizumab for the treatment of advanced malignancies
Ronnie Shapira-Frommer, Jiaxin Niu, Ruth Perets, et al.
Cancer Discovery
|
February 10, 2021
Nongenetic Evolution Drives Lung Adenocarcinoma Spatial Heterogeneity and Progression
Daniele Tavernari, Elena Battistello, Elie Dheilly, et al.
Page
of 37
Search research articles
Search
Showing results (151-160 of 362) with videos related to
Sort By:
Page
of 37
Translational Oncology
|
May 20, 2014
Low-Dose Vascular Photodynamic Therapy Decreases Tumor Interstitial Fluid Pressure, which Promotes Liposomal Doxorubicin Distribution in a Murine Sarcoma Metastasis Model
Jean Yannis Perentes, Yabo Wang, Xingyu Wang, et al.
Translational Lung Cancer Research
|
February 11, 2021
Impact of an enhanced recovery after surgery pathway on thoracoscopic lobectomy outcomes in non-small cell lung cancer patients: a propensity score-matched study
Céline Forster, Valérie Doucet, Jean Yannis Perentes, et al.
Cancer Treatment Reviews
|
May 11, 2024
NTRK gene fusion testing and management in lung cancer
Matteo Repetto, Marina Chiara Garassino, Herbert H Loong, et al.
Journal for Immunotherapy of Cancer
|
October 25, 2022
Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse events
Alexander Coukos, Julien Vionnet, Michel Obeid, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 7, 2020
Quantifying potential confounders of panel-based tumor mutational burden (TMB) measurement
Jan Budczies, Daniel Kazdal, Michael Allgäuer, et al.
Nature Communications
|
May 1, 2024
Primary prophylaxis with mTOR inhibitor enhances T cell effector function and prevents heart transplant rejection during talimogene laherparepvec therapy of squamous cell carcinoma
Victor Joo, Karim Abdelhamid, Alessandra Noto, et al.
Journal of Thoracic Disease
|
March 12, 2026
The value of positron emission tomography scan in predicting pathologic response of non-small cell lung cancer managed by neoadjuvant chemo-immunotherapy
Louis-Emmanuel Chriqui, Maged Zaher, Etienne Abdelnour-Berchtold, et al.
The Lancet. Respiratory Medicine
|
April 13, 2020
Challenges in lung cancer therapy during the COVID-19 pandemic
Luana Calabrò, Solange Peters, Jean-Charles Soria, et al.
Future Oncology (London, England)
|
September 4, 2024
The KEYVIBE program: vibostolimab and pembrolizumab for the treatment of advanced malignancies
Ronnie Shapira-Frommer, Jiaxin Niu, Ruth Perets, et al.
Cancer Discovery
|
February 10, 2021
Nongenetic Evolution Drives Lung Adenocarcinoma Spatial Heterogeneity and Progression
Daniele Tavernari, Elena Battistello, Elie Dheilly, et al.
Page
of 37